BioLife Solutions, Inc. $BLFS Stake Cut by Geneva Capital Management LLC

Geneva Capital Management LLC cut its stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 12.8% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 507,779 shares of the medical equipment provider’s stock after selling 74,362 shares during the quarter. Geneva Capital Management LLC owned about 1.04% of BioLife Solutions worth $19,727,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. First Trust Capital Management L.P. purchased a new position in shares of BioLife Solutions during the 3rd quarter worth $55,365,000. Dimensional Fund Advisors LP grew its holdings in shares of BioLife Solutions by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 1,035,757 shares of the medical equipment provider’s stock valued at $19,761,000 after purchasing an additional 10,587 shares during the period. Bank of America Corp DE grew its holdings in shares of BioLife Solutions by 73.4% in the first quarter. Bank of America Corp DE now owns 904,103 shares of the medical equipment provider’s stock valued at $17,250,000 after purchasing an additional 382,776 shares during the period. Royal Bank of Canada grew its holdings in shares of BioLife Solutions by 8.1% in the first quarter. Royal Bank of Canada now owns 885,298 shares of the medical equipment provider’s stock valued at $16,891,000 after purchasing an additional 66,010 shares during the period. Finally, Granahan Investment Management LLC increased its position in BioLife Solutions by 49.7% during the first quarter. Granahan Investment Management LLC now owns 722,057 shares of the medical equipment provider’s stock worth $13,777,000 after purchasing an additional 239,701 shares during the last quarter. 93.24% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently commented on BLFS shares. Weiss Ratings raised shares of BioLife Solutions from a “sell (d-)” rating to a “hold (c)” rating in a research report on Tuesday, September 22nd. Benchmark cut shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research report on Monday, August 10th. HC Wainwright downgraded BioLife Solutions from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $32.00 to $31.00 in a research report on Thursday, July 23rd. Jefferies Financial Group downgraded shares of BioLife Solutions from a “buy” rating to a “hold” rating and boosted their target price for the stock from $30.00 to $31.00 in a research note on Thursday, July 23rd. Finally, Stephens lowered BioLife Solutions from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $32.00 to $31.00 in a report on Monday, July 27th. One analyst has rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $31.38.

Read Our Latest Analysis on BLFS

BioLife Solutions Price Performance

Shares of NASDAQ BLFS opened at $38.61 on Monday. The business has a 50-day moving average price of $37.93 and a 200 day moving average price of $28.64. The stock has a market cap of $1.89 billion, a PE ratio of 33.28 and a beta of 1.82. BioLife Solutions, Inc. has a 52-week low of $17.86 and a 52-week high of $39.76.

BioLife Solutions Company Profile

(Free Report)

BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.

Further Reading

Institutional Ownership by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.